PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: aazadi@sums.ac.ir.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0306-9877(20)31312-810.1016/j.mehy.2020.110111
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 32721805
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32721805>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32721805>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all